Multiple drug antiretroviral therapy containing lamivudine has been shown to be effective in antiretrovirally-naive patients as well as in patients presenting with viruses containing the M184V mutations.
Lamivudiini sisaldav kombineeritud ravi on efektiivne nii eelnevat retroviiruste vastast ravi mittesaanud patsientidel kui patsientidel, kelle viirused sisaldavad M184V mutatsioone.